Back to Results
First PageMeta Content
Nootropics / Pharmacology / Amphetamines / Childhood psychiatric disorders / Stimulants / Attention deficit hyperactivity disorder / Adult attention deficit hyperactivity disorder / Methylphenidate / Dextroamphetamine / Attention-deficit hyperactivity disorder / Psychiatry / Medicine


CLINICAL POLICY DEPARTMENT: Pharmacy PAGE: 1 of 5 EFFECTIVE DATE: 4/12 APPROVED DATE: 4/12 PRODUCT TYPE: All
Add to Reading List

Document Date: 2014-09-11 16:48:48

Open Document

File Size: 69,80 KB

Share Result on Facebook

City

Arlington / /

Company

Centene / /

Facility

Pharmacy PAGE / /

IndustryTerm

Treatment of Attention Deficit Hyperactivity Disorder / /

MedicalCondition

glaucoma / Attention Deficit Hyperactivity Disorder / vascular disease / ADHD / severe depression / disease / documented hypertension / partial complex seizures / Attention Deficit Disorder / traumatic head injury / Mental Disorders / hyperthyroidism / /

MedicalTreatment

pharmacotherapy / /

Organization

American Psychiatric Association / FDA / American Academy of Centene Medical Policy Statements / CLINICAL POLICY DEPARTMENT / IN.CP / /

Product

Strattera / Daytrana / Ritalin LA / Concerta / Adderall XR / Dexedrine / Vyvanse / Metadate CD / Focalin XR / /

URL

http /

SocialTag